Fzata, Inc. is a oral biologics biopharmaceutical company based in Halethorpe, MD within the vibrant BioHealth Capital Region. Fzata’s vision is to reduce health inequities by expanding patient access to therapeutic biologics. This is made possible with our proprietary first-in-class oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. BioPYM enables orally administered yeast micro-factories to make biologic therapeutics “on-site” in the gut for treatment of GI disorders like infectious diseases, inflammation, metabolic diseases, (e.g., diabetes), colon cancer, and more. Our oral biologic drug candidates are intended to help patients that inject biologic medicine by 1) offering affordable, non-refrigerated, convenient oral capsules, 2) improving quality of life with no needles and no need for health-care administration and 3) improving patient outcomes with expected high safety and high efficacy targeted to GI.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
2-10 employees
-
Headquarters
-
Halethorpe, Maryland
-
Type
-
Privately Held
-
Founded
-
2015
-
Specialties
-
Biologics , Antibodies, Therapeutics, Nanobodies, Gastrointestinal, SYNBIO, Inflammatory Bowel Disease, and C. diff Infection